Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Journal of Immunological Methods
|
February 27, 2001
Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies
B Stockmeyer, D Elsässer, M Dechant, et al.
Mechanisms of Development
|
July 1, 1997
Spx1, a novel X-linked homeobox gene expressed during spermatogenesis
W W Branford, G Q Zhao, M T Valerius, et al.
Molecular and Cellular Biology
|
February 1, 1995
Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequences
B J Aronow, C A Ebert, M T Valerius, et al.
Blood
|
August 1, 1993
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy
T Valerius, R Repp, T P de Wit, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1996
In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects
H M Lorenz, C Antoni, T Valerius, et al.
Journal of Hematotherapy
|
October 1, 1995
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210)
R Repp, T Valerius, G Wieland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1996
Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation
M Eisenhut, W D Lehmann, W Becker, et al.
Cancer Research
|
February 15, 1997
Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer
B Stockmeyer, T Valerius, R Repp, et al.
The Journal of Urology
|
January 17, 2002
Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma?
H Stadick, B Stockmeyer, R Kühn, et al.
Blood
|
May 1, 1996
HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor
D Elsässer, T Valerius, R Repp, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Journal of Immunological Methods
|
February 27, 2001
Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies
B Stockmeyer, D Elsässer, M Dechant, et al.
Mechanisms of Development
|
July 1, 1997
Spx1, a novel X-linked homeobox gene expressed during spermatogenesis
W W Branford, G Q Zhao, M T Valerius, et al.
Molecular and Cellular Biology
|
February 1, 1995
Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequences
B J Aronow, C A Ebert, M T Valerius, et al.
Blood
|
August 1, 1993
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy
T Valerius, R Repp, T P de Wit, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1996
In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects
H M Lorenz, C Antoni, T Valerius, et al.
Journal of Hematotherapy
|
October 1, 1995
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210)
R Repp, T Valerius, G Wieland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1996
Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation
M Eisenhut, W D Lehmann, W Becker, et al.
Cancer Research
|
February 15, 1997
Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer
B Stockmeyer, T Valerius, R Repp, et al.
The Journal of Urology
|
January 17, 2002
Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma?
H Stadick, B Stockmeyer, R Kühn, et al.
Blood
|
May 1, 1996
HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor
D Elsässer, T Valerius, R Repp, et al.
Page
of 7